The enzymatic synthesis of biologically active compounds is receiving increasing interest from academic and industrial researchers. Herein, we report on the continuous-flow enzymatic production of eugenol esters with packed-bed microreactors prepared with the Novozym 435 and Lipozyme RM IM lipases. After optimization of the independent process variables, namely temperature (68 °C), flow rate (8 μL min −1 ), and eugenol/isobutyric anhydride molar ratio (1 : 5) by means of experimental design methodologies, the unprecedented continuous-flow production of eugenyl isobutyrate has been achieved with steady-state conversions of 77 and 70%, using packed-bed microreactors prepared with Novozym 435 and Lipozyme RM IM, respectively. With acetic anhydride as the acylating agent, the same reactors, under the same conditions, afforded eugenyl acetate with steady-state conversions of 82% (Novozym 435) and 90% (Lipozyme RM IM). The two ester products have been tested against phytopathogenic and dermatophytic fungi, demonstrating interesting action against dermatophytic fungi. The reported results demonstrated the suitability of the enzymatic packed-bed microreactors as a sustainable and scalable technology for the solvent-free continuous-flow production of biologically active esters of eugenol.

Continuous production of eugenol esters using enzymatic packed-bed microreactors and an evaluation of the products as antifungal agents

Giovannini P. P.
Primo
;
Catani M.
Secondo
;
Massi A.;Sacchetti G.;Tacchini M.;Lerin L. A.
Ultimo
2019

Abstract

The enzymatic synthesis of biologically active compounds is receiving increasing interest from academic and industrial researchers. Herein, we report on the continuous-flow enzymatic production of eugenol esters with packed-bed microreactors prepared with the Novozym 435 and Lipozyme RM IM lipases. After optimization of the independent process variables, namely temperature (68 °C), flow rate (8 μL min −1 ), and eugenol/isobutyric anhydride molar ratio (1 : 5) by means of experimental design methodologies, the unprecedented continuous-flow production of eugenyl isobutyrate has been achieved with steady-state conversions of 77 and 70%, using packed-bed microreactors prepared with Novozym 435 and Lipozyme RM IM, respectively. With acetic anhydride as the acylating agent, the same reactors, under the same conditions, afforded eugenyl acetate with steady-state conversions of 82% (Novozym 435) and 90% (Lipozyme RM IM). The two ester products have been tested against phytopathogenic and dermatophytic fungi, demonstrating interesting action against dermatophytic fungi. The reported results demonstrated the suitability of the enzymatic packed-bed microreactors as a sustainable and scalable technology for the solvent-free continuous-flow production of biologically active esters of eugenol.
Giovannini, P. P.; Catani, M.; Massi, A.; Sacchetti, G.; Tacchini, M.; de Oliveira, D.; Lerin, L. A.
File in questo prodotto:
File Dimensione Formato  
MS-Eugenyl_esters-FFJ-IRIS-EMBARGO.pdf

accesso aperto

Descrizione: Articolo pre-referaggio
Tipologia: Pre-print
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 402.71 kB
Formato Adobe PDF
402.71 kB Adobe PDF Visualizza/Apri
editoriale.continuous production eugenol2019.pdf

solo gestori archivio

Descrizione: versione editoriale
Tipologia: Full text (versione editoriale)
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 652.27 kB
Formato Adobe PDF
652.27 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2406919
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 9
social impact